Review



human cd4+ t cell enrichment column  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    R&D Systems human cd4+ t cell enrichment column
    Human Cd4+ T Cell Enrichment Column, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd4++t+cell+enrichment+column/human+cd4++t+cell+enrichment+column/us10980797-363-13-19
    Average 90 stars, based on 1 article reviews
    human cd4+ t cell enrichment column - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Monoclonal antibodies to programmed death 1 (PD-1)
    Article Snippet: Human T-cells were purified from PBMC using a human CD4+ T cell enrichment column (R&D systems).

    Article Title: Monoclonal antibodies to programmed death 1 (PD-1)
    Article Snippet: Human T-cells were purified from PBMC using a human CD4+ T cell enrichment column (R&D systems).

    Article Title: Peyerʼs Patches Play a Protective Role in Nonsteroidal Anti-inflammatory Drug-induced Enteropathy in Mice
    Article Snippet: CD4+ CD62L+ naive T cells were isolated from the spleens of BALB/c mice using a naive CD4+ T-cell enrichment column (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions.

    Article Title: Monoclonal antibodies to programmed death 1 (PD-1)
    Article Snippet: Human T-cells were purified from PBMC using a human CD4+ T cell enrichment column (R&D systems).

    Article Title: Monoclonal antibodies to Programmed Death 1 (PD-1)
    Article Snippet: Human T-cells were purified from PBMC using a human CD4+ T cell enrichment column (R&D systems).

    Article Title: Anti-VEGF-PD1 bispecific antibody with novel structure and use thereof
    Article Snippet: The Ficoll centrifugation method (purchased from GE) and CD4+ T cell enrichment column (purchased from R&D Systems) were used to prepare fresh PBMC and purify human T cells.

    Article Title: Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
    Article Snippet: In one exemplary assay, human T cells are purified from PBMCs using a human CD4+ T cell enrichment column (R&D systems).

    Article Title: Methods for treating cancer using anti-PD-1 antibodies
    Article Snippet: Human T-cells were purified from PBMC using a human CD4+ T-cell enrichment column (R&D systems).



    Similar Products

    human cd4+ t cell enrichment column  (R&D Systems)
    90
    R&D Systems human cd4+ t cell enrichment column
    Human Cd4+ T Cell Enrichment Column, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd4++t+cell+enrichment+column/human+cd4++t+cell+enrichment+column/us10980797-363-13-19
    Average 90 stars, based on 1 article reviews
    human cd4+ t cell enrichment column - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human cd4+ or cd8+ t cell enrichment column kit  (Miltenyi Biotec)
    90
    Miltenyi Biotec human cd4+ or cd8+ t cell enrichment column kit
    LOX-1+ PMN is a population of PMN-MDSC in GBM patient PB. ( A, B ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from PB of GBM patients in allogeneic MLR. The data indicate the mean±sem of three independent experiments. <t>CD4+T</t> cell ( A ) and CD8+ T cell ( B ) proliferation was determined in triplicates using 3H-thymidine uptake. ( C ) Production of ROS in LOX-1+ and LOX-1− PMN from six patients with GBM. Production of ROS was detected by staining with DCFDA. ( D, E ) ARG1 ( D ) and iNOS ( E ) expression in LOX-1- and LOX-1+ PMN from six patients with GBM detected by qPCR. ( F, G ) Effect of 1 μM of N-acetyl L-cysteine (NAC), 1,000 U/mL of catalase and 20 μM nor-NOHA on immune suppressive function of LOX-1+ PMN. The data indicate the mean±sem of three independent experiments. Allogeneic MLR and 1:1 PMN: T cell ratio was used in all experiments. CD4+T cell ( F ) and CD8+ T cell ( G ) proliferation were determined in triplicates by 3H-thymidine incorporation. ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood; CPM, counts per minute.
    Human Cd4+ Or Cd8+ T Cell Enrichment Column Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd4++t+cell+enrichment+column/cd14/pmc06683959-48-21-30
    Average 90 stars, based on 1 article reviews
    human cd4+ or cd8+ t cell enrichment column kit - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human cd4+ t-cell enrichment column  (R&D Systems)
    90
    R&D Systems human cd4+ t-cell enrichment column
    LOX-1+ PMN is a population of PMN-MDSC in GBM patient PB. ( A, B ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from PB of GBM patients in allogeneic MLR. The data indicate the mean±sem of three independent experiments. <t>CD4+T</t> cell ( A ) and CD8+ T cell ( B ) proliferation was determined in triplicates using 3H-thymidine uptake. ( C ) Production of ROS in LOX-1+ and LOX-1− PMN from six patients with GBM. Production of ROS was detected by staining with DCFDA. ( D, E ) ARG1 ( D ) and iNOS ( E ) expression in LOX-1- and LOX-1+ PMN from six patients with GBM detected by qPCR. ( F, G ) Effect of 1 μM of N-acetyl L-cysteine (NAC), 1,000 U/mL of catalase and 20 μM nor-NOHA on immune suppressive function of LOX-1+ PMN. The data indicate the mean±sem of three independent experiments. Allogeneic MLR and 1:1 PMN: T cell ratio was used in all experiments. CD4+T cell ( F ) and CD8+ T cell ( G ) proliferation were determined in triplicates by 3H-thymidine incorporation. ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood; CPM, counts per minute.
    Human Cd4+ T Cell Enrichment Column, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd4++t+cell+enrichment+column/human+cd4++t+cell+enrichment+column/us09084776-1274-8-13
    Average 90 stars, based on 1 article reviews
    human cd4+ t-cell enrichment column - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human cd4 cd45ro naive t cell enrichment column  (R&D Systems)
    94
    R&D Systems human cd4 cd45ro naive t cell enrichment column
    LOX-1+ PMN is a population of PMN-MDSC in GBM patient PB. ( A, B ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from PB of GBM patients in allogeneic MLR. The data indicate the mean±sem of three independent experiments. <t>CD4+T</t> cell ( A ) and CD8+ T cell ( B ) proliferation was determined in triplicates using 3H-thymidine uptake. ( C ) Production of ROS in LOX-1+ and LOX-1− PMN from six patients with GBM. Production of ROS was detected by staining with DCFDA. ( D, E ) ARG1 ( D ) and iNOS ( E ) expression in LOX-1- and LOX-1+ PMN from six patients with GBM detected by qPCR. ( F, G ) Effect of 1 μM of N-acetyl L-cysteine (NAC), 1,000 U/mL of catalase and 20 μM nor-NOHA on immune suppressive function of LOX-1+ PMN. The data indicate the mean±sem of three independent experiments. Allogeneic MLR and 1:1 PMN: T cell ratio was used in all experiments. CD4+T cell ( F ) and CD8+ T cell ( G ) proliferation were determined in triplicates by 3H-thymidine incorporation. ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood; CPM, counts per minute.
    Human Cd4 Cd45ro Naive T Cell Enrichment Column, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd4++t+cell+enrichment+column/Recombinant+Human+CD45RO+Fc+Chimera+Protein%2C+CF/pmc02265931-95-13-23
    Average 94 stars, based on 1 article reviews
    human cd4 cd45ro naive t cell enrichment column - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    LOX-1+ PMN is a population of PMN-MDSC in GBM patient PB. ( A, B ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from PB of GBM patients in allogeneic MLR. The data indicate the mean±sem of three independent experiments. CD4+T cell ( A ) and CD8+ T cell ( B ) proliferation was determined in triplicates using 3H-thymidine uptake. ( C ) Production of ROS in LOX-1+ and LOX-1− PMN from six patients with GBM. Production of ROS was detected by staining with DCFDA. ( D, E ) ARG1 ( D ) and iNOS ( E ) expression in LOX-1- and LOX-1+ PMN from six patients with GBM detected by qPCR. ( F, G ) Effect of 1 μM of N-acetyl L-cysteine (NAC), 1,000 U/mL of catalase and 20 μM nor-NOHA on immune suppressive function of LOX-1+ PMN. The data indicate the mean±sem of three independent experiments. Allogeneic MLR and 1:1 PMN: T cell ratio was used in all experiments. CD4+T cell ( F ) and CD8+ T cell ( G ) proliferation were determined in triplicates by 3H-thymidine incorporation. ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood; CPM, counts per minute.

    Journal: Cancer Management and Research

    Article Title: LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression

    doi: 10.2147/CMAR.S210545

    Figure Lengend Snippet: LOX-1+ PMN is a population of PMN-MDSC in GBM patient PB. ( A, B ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from PB of GBM patients in allogeneic MLR. The data indicate the mean±sem of three independent experiments. CD4+T cell ( A ) and CD8+ T cell ( B ) proliferation was determined in triplicates using 3H-thymidine uptake. ( C ) Production of ROS in LOX-1+ and LOX-1− PMN from six patients with GBM. Production of ROS was detected by staining with DCFDA. ( D, E ) ARG1 ( D ) and iNOS ( E ) expression in LOX-1- and LOX-1+ PMN from six patients with GBM detected by qPCR. ( F, G ) Effect of 1 μM of N-acetyl L-cysteine (NAC), 1,000 U/mL of catalase and 20 μM nor-NOHA on immune suppressive function of LOX-1+ PMN. The data indicate the mean±sem of three independent experiments. Allogeneic MLR and 1:1 PMN: T cell ratio was used in all experiments. CD4+T cell ( F ) and CD8+ T cell ( G ) proliferation were determined in triplicates by 3H-thymidine incorporation. ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood; CPM, counts per minute.

    Article Snippet: The isolation of CD4+ or CD8+ T cells from the PBMC of the same patients as LOX-1+ PMN was performed using human CD4+ or CD8+ T Cell Enrichment Column Kit (Miltenyi).

    Techniques: Staining, Expressing

    LOX-1+ PMN is negatively correlation with effector immune cells in GBM patient PB. ( A ) Typical example of the analysis of the proportion of LOX-1+ PMN, IFN-γ+CD4+ T cells and IFN-γ+CD8+ T cells in two patients with GBM. ( B, C ) Quantification showing the associations between LOX-1+ PMN and IFN-γ+CD4+ T cells ( B ) and IFN-γ+CD8+ T cells in 10 patients with GBM ( C ). Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood.

    Journal: Cancer Management and Research

    Article Title: LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression

    doi: 10.2147/CMAR.S210545

    Figure Lengend Snippet: LOX-1+ PMN is negatively correlation with effector immune cells in GBM patient PB. ( A ) Typical example of the analysis of the proportion of LOX-1+ PMN, IFN-γ+CD4+ T cells and IFN-γ+CD8+ T cells in two patients with GBM. ( B, C ) Quantification showing the associations between LOX-1+ PMN and IFN-γ+CD4+ T cells ( B ) and IFN-γ+CD8+ T cells in 10 patients with GBM ( C ). Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; PB, peripheral blood.

    Article Snippet: The isolation of CD4+ or CD8+ T cells from the PBMC of the same patients as LOX-1+ PMN was performed using human CD4+ or CD8+ T Cell Enrichment Column Kit (Miltenyi).

    Techniques:

    LOX-1 defines a subset of PMN-MDSC in GBM patient tissues. ( A) Typical example of the analysis of PMN in GBM patient tissue. ( B, C ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from tumor tissue of GBM patients in allogeneic MLR. CD4+T cell ( B ) and CD8+ T cell ( C ) proliferation was determined in triplicates using 3H-thymidine uptake. ( D ) Production of ROS in LOX-1+ and LOX-1− PMN from five patients with GBM. Production of ROS was detected by staining with DCFDA. ( E, F ) ARG1 ( E ) and iNOS ( F ) expression in LOX-1- and LOX-1+ PMN from five patients with GBM detected by qPCR. * P <0.05, ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; MDSC, myeloid-derived suppressor cell; DCFDA, dichlorodihydrofluorescein diacetate; MLR, mixed lymphocyte reaction; n.s, not significant.

    Journal: Cancer Management and Research

    Article Title: LOX-1+ PMN-MDSC enhances immune suppression which promotes glioblastoma multiforme progression

    doi: 10.2147/CMAR.S210545

    Figure Lengend Snippet: LOX-1 defines a subset of PMN-MDSC in GBM patient tissues. ( A) Typical example of the analysis of PMN in GBM patient tissue. ( B, C ) Suppressive function of LOX-1+ and LOX-1− PMN sorted from tumor tissue of GBM patients in allogeneic MLR. CD4+T cell ( B ) and CD8+ T cell ( C ) proliferation was determined in triplicates using 3H-thymidine uptake. ( D ) Production of ROS in LOX-1+ and LOX-1− PMN from five patients with GBM. Production of ROS was detected by staining with DCFDA. ( E, F ) ARG1 ( E ) and iNOS ( F ) expression in LOX-1- and LOX-1+ PMN from five patients with GBM detected by qPCR. * P <0.05, ** P <0.01, *** P <0.001. Abbreviations: LOX-1, lectin-type oxidized LDL receptor 1; PMN, polymorphonuclear neutrophil; GBM, glioblastoma multiforme; MDSC, myeloid-derived suppressor cell; DCFDA, dichlorodihydrofluorescein diacetate; MLR, mixed lymphocyte reaction; n.s, not significant.

    Article Snippet: The isolation of CD4+ or CD8+ T cells from the PBMC of the same patients as LOX-1+ PMN was performed using human CD4+ or CD8+ T Cell Enrichment Column Kit (Miltenyi).

    Techniques: Staining, Expressing, Derivative Assay